PAERX Performance — T. Rowe Price Target 2010 Fund, Advisor Class
Data updated: 2026-08-12
PAERX returned +4.48% year to date and +11.64% over one year to May 2026. Annualised returns are +9.58% over 3 years and +3.97% over 5 years. The fund trailed its Target-Date category average: $100 invested three years ago grew to $132, against $155 for the category, and to $112 over one year, against $121. Volatility over the past three years was 5.96% a year. In the 12 months to May 2026 the fund lost a net $144K, and assets reached $69.98M.
PAERX Growth of $100
What $100 invested in T. Rowe Price Target 2010 Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Target-Date category average over the same months.
| Period | PAERX | Category average |
|---|---|---|
| 1 year (Jun 2025 – May 2026) | $112 | $121 |
| 3 years (Jun 2023 – May 2026) | $132 | $155 |
| 5 years (Jun 2021 – May 2026) | $121 | $144 |
| Since data start (Sep 2019 – May 2026) | $146 | $187 |
PAERX Trailing Returns
Total returns to May 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +4.48% |
| 1 year | +11.64% |
| 3 years (annualised) | +9.58% |
| 5 years (annualised) | +3.97% |
PAERX Annual Returns
Calendar-year total returns of T. Rowe Price Target 2010 Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–May) | +4.48% |
| 2025 | +10.24% |
| 2024 | +6.98% |
| 2023 | +10.51% |
| 2022 | −12.95% |
| 2021 | +7.11% |
| 2020 | +10.70% |
| 2019 (Sep–Dec) | +4.02% |
PAERX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +1.5% | +1.4% | −3.2% | +3.5% | +1.4% | — | — | — | — | — | — | — |
| 2025 | +1.7% | +0.8% | −1.0% | +0.1% | +1.5% | +1.9% | +0.3% | +1.6% | +1.4% | +0.7% | +0.4% | +0.3% |
| 2024 | −0.1% | +1.3% | +1.8% | −2.0% | +2.1% | +0.8% | +1.7% | +1.5% | +1.3% | −1.5% | +2.0% | −2.0% |
| 2023 | +3.9% | −1.7% | +1.8% | +0.7% | −1.1% | +1.9% | +1.4% | −1.1% | −2.4% | −1.4% | +4.8% | +3.6% |
| 2022 | −2.7% | −1.3% | −0.3% | −4.4% | −0.1% | −4.1% | +3.6% | −2.5% | −5.5% | +1.8% | +4.2% | −2.0% |
| 2021 | −0.2% | +1.0% | +0.8% | +2.1% | +0.7% | +0.6% | +0.8% | +0.9% | −1.7% | +1.7% | −1.1% | +1.2% |
| 2020 | +0.2% | −2.3% | −8.5% | +5.9% | +2.9% | +2.0% | +3.0% | +2.1% | −1.3% | −0.7% | +5.3% | +2.4% |
| 2019 | — | — | — | — | — | — | — | — | +0.3% | +0.9% | +1.0% | +1.7% |
PAERX Risk
Risk measures from monthly returns over Jun 2023 – May 2026.
- 3-year volatility (annualised): 5.96%
- 3-year Sharpe ratio: 0.85 (vs 4.5% risk-free rate)
- Best month: +4.79% (Nov 2023)
- Worst month: −3.18% (Mar 2026)
PAERX Fund Flows
Monthly money in and out of T. Rowe Price Target 2010 Fund, from SEC Form N-PORT.
- 12-month net flow: −$144K
- 12-month gross sales (incl. reinvestments): $12.9M
- Sales ÷ redemptions: 0.99×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| May 2026 | $94K | $994K | −$900K |
| Apr 2026 | $820K | $672K | $148K |
| Mar 2026 | $95K | $1.4M | −$1.3M |
| Feb 2026 | $1.1M | $757K | $342K |
| Jan 2026 | $1.6M | $1.7M | −$139K |
| Dec 2025 | $4.0M | $1.5M | $2.5M |
| Nov 2025 | $1.5M | $830K | $627K |
| Oct 2025 | $232K | $506K | −$274K |
| Sep 2025 | $403K | $716K | −$313K |
| Aug 2025 | $2.8M | $1.2M | $1.7M |
| Jul 2025 | $93K | $2.5M | −$2.4M |
| Jun 2025 | $215K | $290K | −$75K |
PAERX Assets Under Management
Net assets of T. Rowe Price Target 2010 Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-05-31 | $69.98M |
| 2026-02-28 | $70.91M |
| 2025-11-30 | $69.50M |
| 2025-08-31 | $67.67M |
| 2025-05-31 | $65.84M |
| 2025-02-28 | $67.38M |
| 2024-11-30 | $70.56M |
| 2024-08-31 | $71.31M |
| 2024-05-31 | $69.23M |
| 2024-02-29 | $70.14M |
| 2023-11-30 | $66.79M |
| 2023-08-31 | $69.80M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.